|
| 38021355 | Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2023 |
| 36425756 | Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. | iScience | 2022 |
| 34834585 | Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. | J Pers Med | 2021 |
| 31269236 | Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. | Int J Cancer | 2020 |
| 32726984 | Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways. | Cancers (Basel) | 2020 |
| 31282843 | HPV Status Improves Classification of Head and Neck Gray Zone Cancers. | J Dent Res | 2019 |
| 31665182 | Correction:Â Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. | PLoS One | 2019 |
| 31355511 | Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis. | Mol Carcinog | 2019 |
| 28892201 | Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma. | Mol Carcinog | 2018 |
| 29894502 | Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer. | PLoS One | 2018 |
| 29715275 | Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. | PLoS One | 2018 |
| 26822871 | Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments. | Dis Esophagus | 2017 |
| 28427211 | Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome. | Oncotarget | 2017 |
| 28915692 | Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patients. | Oncotarget | 2017 |
| 28074552 | Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival. | Cancer Med | 2017 |
| 27827316 | BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial. | Clin Cancer Res | 2017 |
| 26816351 | ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. | Cancer Epidemiol | 2016 |
| 27173062 | A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways. | Cancer Epidemiol | 2016 |
| 27487558 | BRM polymorphisms, pancreatic cancer risk and survival. | Int J Cancer | 2016 |
| 27179112 | Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer. | Clin Cancer Res | 2016 |
| 26014353 | Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. | Carcinogenesis | 2015 |
| 23529007 | Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. | Pharmacogenomics J | 2014 |
| 24519853 | Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. | Cancer Med | 2014 |
| 24679952 | A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). | Lung Cancer | 2014 |
| 23322154 | Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk. | Carcinogenesis | 2013 |
| 24349265 | Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis. | PLoS One | 2013 |
| 23516488 | Association between UGT1A1*28 polymorphisms and clinical outcomes of irinotecan-based chemotherapies in colorectal cancer: a meta-analysis in Caucasians. | PLoS One | 2013 |
| 23169318 | Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. | Int J Cancer | 2013 |
| 22009713 | Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. | Cancer | 2012 |
| 22719940 | Distribution of HLA-A, -B and -DRB1 genes and haplotypes in the Tujia population living in the Wufeng Region of Hubei Province, China. | PLoS One | 2012 |
| 22539604 | Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue. | Cancer Epidemiol Biomarkers Prev | 2012 |
| 22237259 | Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer. | J Thorac Oncol | 2012 |
| 22076708 | Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. | Clin Cancer Res | 2012 |
| 21478907 | Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. | Oncogene | 2011 |
| 19125649 | Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells. | Tissue Eng Part A | 2009 |
| 18181105 | Effect of mouse VEGF164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: bioluminescence imaging. | J Biomed Mater Res A | 2008 |